These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17230068)

  • 1. Matched unrelated bone marrow transplantation without splenectomy for a child with Gaucher disease caused by homozygosity of the L444P mutation, who also suffered from schizencephaly.
    Chen RL; Hou JW; Chang PY; Tsai FJ; Wang PJ
    J Pediatr Hematol Oncol; 2007 Jan; 29(1):57-9. PubMed ID: 17230068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
    Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
    Chabás A; Gort L; Díaz-Font A; Montfort M; Santamaría R; Cidrás M; Grinberg D; Vilageliu L
    Blood Cells Mol Dis; 2005; 35(2):253-8. PubMed ID: 15967693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
    Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
    Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation for Gaucher disease--a case report.
    Yen CC; Chiou TJ; Lin CY; Wang NH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jun; 59(6):372-6. PubMed ID: 9294918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective cell and gene therapy in a murine model of Gaucher disease.
    Enquist IB; Nilsson E; Ooka A; Månsson JE; Olsson K; Ehinger M; Brady RO; Richter J; Karlsson S
    Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13819-24. PubMed ID: 16954197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation in Gaucher's disease: effect of mixed chimeric state.
    Chan KW; Wong LT; Applegarth D; Davidson AG
    Bone Marrow Transplant; 1994 Aug; 14(2):327-30. PubMed ID: 7994251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant lymphadenopathy infiltrated by gaucher cells mimicking lymphoma.
    Yağci B; Salor O; Yalçin B; Gürakan F; Güçer S; Büyükpamukçu M
    Pediatr Blood Cancer; 2009 Jul; 52(7):870-1. PubMed ID: 19213078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP
    Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
    Kim EA; Lim YT; Hah JO; Sohn YB; Kim YK; Choi JH; Kim SY; Jang KM; Ahn J; Lee JM
    Int J Hematol; 2019 Mar; 109(3):361-365. PubMed ID: 30456712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
    Piran S; Roberts A; Patterson MA; Amato D
    Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
    Erikson A
    Acta Paediatr Scand Suppl; 1986; 326():1-42. PubMed ID: 3296644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM
    Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenotype and mutational spectrum in Tunisian pediatric gaucher disease].
    Ben Turkia H; Riahi I; Azzouz H; Ladab S; Cherif W; Ben Chehida A; Abdelmoula MS; Caillaud C; Chemli J; Abdelhak S; Tebib N; Ben Dridi MF
    Tunis Med; 2010 Mar; 88(3):158-62. PubMed ID: 20415187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attempt at enzyme replacement in Gaucher disease by renal transplantation.
    Groth CG; Collste H; Dreborg S; Håkansson G; Lundgren G; Svennerholm L
    Acta Paediatr Scand; 1979 Jul; 68(4):475-9. PubMed ID: 380259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years' experience of bone marrow transplantation for Gaucher disease.
    Ringdén O; Groth CG; Erikson A; Granqvist S; Månsson JE; Sparrelid E
    Transplantation; 1995 Mar; 59(6):864-70. PubMed ID: 7701581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher disease: haematological presentations and complications.
    Thomas AS; Mehta A; Hughes DA
    Br J Haematol; 2014 May; 165(4):427-40. PubMed ID: 24588457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
    Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.